111
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Knock-down of IGFBP2 ameliorates lung fibrosis and inflammation in rats with severe pneumonia through STAT3 pathway

, , , &
Pages 210-220 | Received 22 Mar 2023, Accepted 05 Sep 2023, Published online: 21 Sep 2023

References

  • Akhtar, J., Z. Wang, C. Yu, and Z. P. Zhang. 2014. “Effectiveness of Local Injection of Lentivirus-Delivered stathmin1 and stathmin1 shRNA in Human Gastric Cancer Xenograft Mouse.” Journal of Gastroenterology and Hepatology 29 (9): 1685–1691. https://doi.org/10.1111/jgh.12594
  • Allard, B., A. Panariti, and J. G. Martin. 2018. “Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection.” Frontiers in Immunology 9: 1777. https://doi.org/10.3389/fimmu.2018.01777
  • Chen, C., L Shi, Y. Li, X. Wang, and S Yang. 2016. “Disease-Specific Dynamic Biomarkers Selected by Integrating Inflammatory Mediators with Clinical Informatics in ARDS Patients with Severe Pneumonia.” Cell Biology and Toxicology 32 (3): 169–184. https://doi.org/10.1007/s10565-016-9322-4
  • Cheng, P., S. Li, and H. Chen. 2021. “Macrophages in Lung Injury, Repair, and Fibrosis.” Cells 10 (2): 436. https://doi.org/10.3390/cells10020436
  • Chin, C., R. Ravichandran, K. Sanborn, T. Fleming, S. B. Wheatcroft, M. T. Kearney, S. Tokman, et al. 2023. “Loss of IGFBP2 Mediates Alveolar Type 2 Cell Senescence and Promotes Lung Fibrosis.” Cell Reports. Medicine 4 (3): 100945. https://doi.org/10.1016/j.xcrm.2023.100945
  • Dong, J., Y. Zeng, P Zhang, C. Li, Y. Chen, Y. Li, K. Wang, et al. 2020. “Serum IGFBP2 Level is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer.” Nutrition and Cancer 72 (5): 858–863. https://doi.org/10.1080/01635581.2019.1656755
  • Fan, E. K. Y., and J. Fan. 2018. “Regulation of Alveolar Macrophage Death in Acute Lung Inflammation.” Respiratory Research 19 (1): 50. https://doi.org/10.1186/s12931-018-0756-5
  • Gajjela, B. K., and M. M. Zhou. 2022. “Calming the Cytokine Storm of COVID-19 through Inhibition of JAK2/STAT3 Signaling.” Drug Discovery Today 27 (2): 390–400. https://doi.org/10.1016/j.drudis.2021.10.016
  • Guiot, J., M. Henket, J. L. Corhay, C. Moermans, and R. Louis. 2017. “Sputum Biomarkers in IPF: Evidence for Raised Gene Expression and Protein Level of IGFBP-2, IL-8 and MMP-7.” PLOS One 12 (2): e0171344. https://doi.org/10.1371/journal.pone.0171344
  • Guo, C., H. Lu, W. Gao, L. Wang, K. Lu, S. Wu, A. Pataer, et al. 2013. “Insulin-like Growth Factor Binding Protein-2 Level is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival.” PLOS One 8 (9): e74973. https://doi.org/10.1371/journal.pone.0074973
  • He, J., and X. Li. 2022. “Identification and Validation of Aging-Related Genes in Idiopathic Pulmonary Fibrosis.” Frontiers in Genetics 13: 780010. https://doi.org/10.3389/fgene.2022.780010
  • Hu, Q., L. Huang, X. Kuang, H. Zhang, G. Ling, X. Chen, K. Li, et al. 2014. “Is Insulin-like Growth Factor Binding Protein 2 Associated with Metastasis in Lung Cancer?” Clinical & Experimental Metastasis 31 (5): 535–541. https://doi.org/10.1007/s10585-014-9647-4
  • Hübner, R.-H., W. Gitter, N E. El Mokhtari, M. Mathiak, M. Both, H. Bolte, S. Freitag-Wolf, et al. 2008. “Standardized Quantification of Pulmonary Fibrosis in Histological Samples.” BioTechniques 44 (4): 507–517. https://doi.org/10.2144/000112729
  • Jwa, M. Y., S. Jeong, E. B. Ko, A. R. Kim, H. Y. Kim, S. K. Kim, H. S. Seo, et al. 2018. “Gamma-Irradiation of Streptococcus pneumoniae for the Use as an Immunogenic Whole Cell Vaccine.” Journal of Microbiology 56 (8): 579–585. https://doi.org/10.1007/s12275-018-8347-1
  • Kabalak, P. A., and A. Esenkyaya. 2016. “Severe Pneumonia Treated Succesfully with Levofloxacin and Oseltamivir during Flu Epidemic.” Turkish Thoracic Journal 17 (2): 84–87. https://doi.org/10.5578/ttj.17.2.018
  • Krutikov, M., A. Rahman, and S. Tiberi. 2019. “Necrotizing Pneumonia (Aetiology, Clinical Features and Management).” Current Opinion in Pulmonary Medicine 25 (3): 225–232. https://doi.org/10.1097/MCP.0000000000000571
  • Leiphrakpam, P. D., et al. 2021. “Rat Model of Smoke Inhalation-Induced Acute Lung Injury.” BMJ Open Respiratory Research 8 (1): e000879.
  • Li, T., C. Zhang, G. Zhao, X. Zhang, M.e Hao, S. Hassan, M. Zhang, et al. 2020. “IGFBP2 Regulates PD-L1 Expression by Activating the EGFR-STAT3 Signaling Pathway in Malignant Melanoma.” Cancer Letters 477: 19–30. https://doi.org/10.1016/j.canlet.2020.02.036
  • Li, Tao., M. E. Forbes, G N. Fuller, J Li, X Yang, and W. Zhang. 2020. “IGFBP2: Integrative Hub of Developmental and Oncogenic Signaling Network.” Oncogene 39 (11): 2243–2257. https://doi.org/10.1038/s41388-020-1154-2
  • Montero, P., et al. 2021. “Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.” International Journal of Molecular Sciences. 22 (12): 6211.
  • Nair, G. B., and M. S. Niederman. 2021. “Updates on Community Acquired Pneumonia Management in the ICU.” Pharmacology & Therapeutics 217: 107663. https://doi.org/10.1016/j.pharmthera.2020.107663
  • Pickard, A., and D. J. McCance. 2015. “IGF-Binding Protein 2 - Oncogene or Tumor Suppressor?” Frontiers in Endocrinology 6: 25. https://doi.org/10.3389/fendo.2015.00025
  • Qu, S., C. Dai, F. Yang, T. Huang, Z. Hao, Q. Tang, H. Wang, et al. 2019. “Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats.” Pharmaceutical Research 36 (5): 74. https://doi.org/10.1007/s11095-019-2614-7
  • Saad Alharbi, K., et al. 2020. “Impact of COVID-19 on Nephrology Patients: A Mechanistic Outlook for Pathogenesis of Acute Kidney Injury.” Altern Ther Health Med 26 (S2): 66–71.
  • Soni, S., M. R. Wilson, K. P. O'Dea, M. Yoshida, U. Katbeh, S. J. Woods, M. Takata, et al. 2016. “Alveolar Macrophage-Derived Microvesicles Mediate Acute Lung Injury.” Thorax 71 (11): 1020–1029. https://doi.org/10.1136/thoraxjnl-2015-208032
  • Sun, L., X. Zhang, Q. Song, L. Liu, E. Forbes, W Tian, Z Zhang, et al. 2021. “IGFBP2 Promotes Tumor Progression by Inducing Alternative Polarization of Macrophages in Pancreatic Ductal Adenocarcinoma through the STAT3 Pathway.” Cancer Letters 500: 132–146. https://doi.org/10.1016/j.canlet.2020.12.008
  • Theoharides, T. C., and P. Conti. 2020. “Dexamethasone for COVID-19? Not so Fast.” J Biol Regul Homeost Agents 34 (3): 1241–1243.
  • Umakanthan, S., et al. 2020. “Origin, Transmission, Diagnosis and Management of Coronavirus Disease 2019 (COVID-19).” Postgrad Med J 96 (1142): 753–758.
  • Wang, C., N. Liu, and H. T. Yang. 2020. “Desflurane Pretreatment Can Reduce Sepsis-Evoked Lung Injury in Rats via Inhibiting STAT3 Pathway.” J Biol Regul Homeost Agents 34 (3): 935–942.
  • Zhang, B., C-Q. Hong, Y-H. Luo, L-F. Wei, Y. Luo, Y-H. Peng, Y-W. Xu, et al. 2022. “Prognostic Value of IGFBP2 in Various Cancers: A Systematic Review and Meta-Analysis.” Cancer Medicine 11 (16): 3035–3047. https://doi.org/10.1002/cam4.4680
  • Zhang, L., Yi Wang, G. Wu, W Xiong, W Gu, and C-Yi. Wang. 2018. “Macrophages: friend or Foe in Idiopathic Pulmonary Fibrosis?” Respiratory Research 19 (1): 170. https://doi.org/10.1186/s12931-018-0864-2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.